Answering Your Frequently Asked Questions
We've collated some of the most frequently asked questions about the Rational Based Drug Design Summit Europe. If you have any additional questions, please contact the team at info@hansonwade.com.
About the Summit
The Rational Drug Design Summit Europe is the dedicated meeting for structural biologists, biophysicists, medicinal chemists, computational chemists and AI drug discovery leaders advancing next-generation therapeutics. The summit explores how structural biology, biophysics, medicinal chemistry and AI are being integrated to improve target identification, molecular design, hit validation and candidate selection.
As structural biology, biophysics, medicinal chemistry and AI become increasingly interconnected, there is growing demand for a dedicated European forum bringing these disciplines together. The summit was created to provide a platform for collaboration, knowledge exchange and practical discussion around accelerating safer, faster and more efficient drug discovery.
Europe is home to a growing community of biopharma organisations investing in rational drug design, structural biology, biophysics and AI-enabled drug discovery. The summit provides a dedicated regional forum where scientists can connect, share insights and learn from peers without the barriers associated with long-distance travel.
Who Should Attend?
The summit is designed for structural biologists, biophysicists, medicinal chemists, computational chemists, AI drug discovery specialists and drug discovery leaders working across pharmaceutical companies, biotechnology organisations and research institutes.
Attendees include Vice Presidents, Directors, Heads of Department, Principal Scientists, Senior Scientists and other discovery professionals responsible for driving drug discovery strategy and execution.
The event brings together large pharmaceutical companies, emerging biotechs, technology innovators, research institutes and solution providers supporting drug discovery and development.
Why Attend?
Topics include rational drug design, structural biology, biophysics, computational chemistry, AI-driven drug discovery, structure-based drug design, cryo-EM, protein structure prediction, target validation, hit identification, molecular design and candidate selection.
Gain practical insights into improving target identification, reducing development risk, accelerating candidate progression and integrating structural, biophysical and computational approaches to make more confident drug discovery decisions.
From structured networking sessions, interactive discussions, roundtables, networking breaks and social functions, our networking sessions are designed to help attendees connect with peers, collaborators and industry leaders.
Meet structural biologists, biophysicists, medicinal chemists, computational chemists, AI specialists and drug discovery leaders from leading biopharma organisations across Europe.
Speakers & Programme
The speaker faculty includes leaders from organisations such as GSK, AstraZeneca, Sanofi, Merck Healthcare, OMass Therapeutics, Bicycle Therapeutics and other leading biopharma innovators.
The latest agenda, speakers and networking opportunities can be accessed by downloading the Full Event Guide.
Sponsorship
Yes. The summit offers a range of sponsorship and exhibition opportunities designed to help organisations connect with senior drug discovery decision-makers and showcase their expertise.
Find out more on the Why Partner page.
The event is particularly relevant for CROs, technology providers, AI platform developers, structural biology and biophysics specialists, equipment providers and organisations supporting drug discovery workflows.
You can reach out to sponsor@hansonwade.com to ask about sponsorship opportunities.
Registration & Contact
You can register through the registration page here. Pricing options are available for drug developers, academic researchers and solution providers.
For registration, speaking, sponsorship or general event enquiries, contact the event team at info@hansonwade.com, or view our Contact Us page for more information.
Explore the Agenda
Discover how leading drug discovery teams are combining structural biology, biophysics, and AI to accelerate therapeutic design, expand the druggable universe, and advance higher-quality candidates into development.
Partner With Us
Position your organisation alongside industry leaders including Sanofi, GSK, and AstraZeneca to connect with decision-makers actively investing in next-generation drug discovery technologies and partnerships.
Join Drug Discovery Leaders
Connect with experts in structural biology, biophysics, computational chemistry, AI, and emerging therapeutic modalities through dedicated networking, interactive discussions, and collaborative roundtable sessions designed to foster meaningful scientific partnerships.